C3i Program - Accelerator

Program Description

The C3i Accell program provides up to 12 months of technical development and business support, leveraging the learnings from the core C3i Program to advance the translation of biomedical technologies.  Investigators with active NIH-funded research projects (K99/R00, R01, U01, or P41), who have recently completed the core C3i Program, may receive administrative supplement funding to address both technical and commercialization risks identified through their entrepreneurial training experience. The Project Teams will continue to receive mentored support from their C3i Business Advisors and Project Managers through frequent teleconferences.

The primary objective of C3i Accell is to complete proof-of-concept studies and facilitate preparations for commercialization through start-up formation, strategic partnership, or out-licensing.  It is expected that Project Teams forming start-up companies will be well-positioned to compete for NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants to further commercial development efforts.

The C3i Accell program is being offered to investigators who have active NIH-funded research projects from participating Institutes and Centers and who have recently completed the core C3i Program. 

Participating Institutes/Centers

The following Institutes and Centers will be participating in the C3i Accell program. Prospective applicants are strongly encouraged to contact NIH Scientific/Research staff for more information about this program before submitting an application.

National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Kari Ashmont
Telephone: 301-451-4772
Email: NIBIB-SBIR@mail.nih.gov

 

Eligibility

The C3i Accell program is being offered to investigators who have active NIH-funded research projects from participating Institutes and Centers and who have recently completed the core C3i Program.  Eligible investigators may submit administrative supplement requests to advance technology development and translational research aims consistent with the peer-reviewed objectives of the parent grant.  Investigators may propose research and development efforts that incorporate the learnings from the C3i Program and take advantage of unanticipated opportunities to increase the value of the project.

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) will support active grant awards from research project (K99/R00, R01, U01, and P41) activity codes.

 

Timeline

Applications Due: Late April

Notice of Participation: Mid May

Program Start Date: Early June

Program Length: Up to 12 months

 

How to Apply

Interested teams should contact the NIBIB Small Business Team: NIBIB-SBIR@mail.nih.gov